Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06582693

Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network

The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19146, United States

Location status: Recruiting

Location contact

Brian P Jenssen, MD, MSHP

CONTACT

[email protected]

267-559-1566

About this study

This study aims to evaluate a proactive and population health-based approach that leverages a clinical decision support (CDS) system embedded in the electronic health record (EHR) to identify household members who smoke but did not complete the smoking survey at the visit, and remotely engage them in tobacco use treatment.

Participants will be recruited through up to 32 outpatient primary care practice from the Children's Hospital of Philadelphia's (CHOP) Pediatric Research Consortium (PeRC). Potential participants will be identified from the cohort of referrals for tobacco cessation treatment. Randomization of adult participants into either the intervention or control group will occur after the participants have consented to partake in the study and completed enrollment. The investigators will deploy a remote recruitment strategy (via phone and/or text) to outreach to eligible adult participants to maximize recruitment efforts.

After the initial referral of the household member who smokes, a study team member will reach out to them, explain the reason they are being contacted and confirm their smoking status and age. All participants will complete the enrollment step with data collection including: adult participant demographics, nicotine dependence and quitting motivation.

Only the intervention arm will receive the opportunity to be automatically connected by the study team to four evidence-based tobacco treatment options: varenicline, nicotine replacement therapy (NRT), quitline, and/or smokefreeTXT. Adult intervention arm participants will also receive brief motivational counseling by the study team.

Adult control arm participants will receive treatment as usual which consistent of a handout of evidence tobacco treatment resources which the adult participant must connect with on their own

Enrolled adult participants in both the intervention and control arms will be followed-up via surveys at approximately 1 and 6-month time intervals. Adult participants who self-report 7-day abstinence at the 1 and 6-month surveys will be asked to confirm smoking cessation through carbon monoxide testing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Adult Intervention Subject Inclusion Criteria

  • Males or females ages ≥18 years in age
  • Self-identify as a current combustible tobacco user
  • Have a valid cell phone number

Child Intervention Subject Inclusion Criteria

  • Must be a CHOP patient

Adult Intervention Subject Exclusion Criteria

  • <18 years in age.
  • Indicates no combustible tobacco smoking

Child Intervention Subject Exclusion Criteria

  • Not a CHOP patient

Adult Control Subject Inclusion Criteria

  • Males or females ages ≥18 years in age
  • Self-identify as a current combustible tobacco user
  • Have a valid cell phone number

Child Control Subject Inclusion Criteria

  • Must be a CHOP patient

Adult Control Subject Exclusion Criteria

  • <18 years in age.
  • Indicates no combustible tobacco smoking

Child Control Subject Exclusion Criteria

  • Not a CHOP patient

Treatment and study plan

Refer2Quit

Other

The Refer2Quit intervention consists of automatic connection to the adult participant's choice of any or all of four evidence-based tobacco treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), as well as motivational counseling provided by the study team. Supportive and motivational text messaging is also included in the intervention to connect or reconnect adult participants to treatments as needed. Text messaging and support would also focus on supporting appropriate use of NRT and/or varenicline if indicated.

Primary outcomes

  1. The proportion of adult participants who engage in any evidence-based tobacco use treatments

    Time frame: Baseline, 1 and 6 months

    The proportion of adult participants who engage in any evidence-based tobacco use treatments, between the intervention and control arms, by adult participant self-report.

  2. Combustible tobacco quit rate at 1 and 6 months

    Time frame: 1 and 6 months

    The quit rate, compared between the intervention and control arms, will be assessed by a self-reported 7-day point prevalence smoking abstinence, collected via follow-up survey, and confirmed via breath carbon monoxide (CO) <5ppm at the time-point

Study contacts

Contact information is provided by the study sponsor or research team.

Brian P Jenssen, MD, MSHP

CONTACT

[email protected]

267-559-1566

Sponsors and collaborators

Lead sponsor

Children's Hospital of Philadelphia

Other

Collaborators

  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Sep 3, 2024
Registry last updated
Aug 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.